top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Natural Killer Cells and Host Defense : : 5th International Natural Killer Cells Workshop, Hilton Head, N.C., March 1988 / / editors, E.W. Ades, C. Lopez
Natural Killer Cells and Host Defense : : 5th International Natural Killer Cells Workshop, Hilton Head, N.C., March 1988 / / editors, E.W. Ades, C. Lopez
Autore Ades E.W
Pubbl/distr/stampa Basel : , : S. Karger, , 1989
Descrizione fisica 1 online resource (XIV + 302 pages) : : 77 figures, 59 tables
Disciplina 616.07/9
Altri autori (Persone) AdesEdwin W
LopezCarlos <1942->
Soggetto topico Immunology
Chemotherapy
Hematology
Infectious Diseases
Microbiology
Virology
ISBN 3-318-04961-1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910149651903321
Ades E.W  
Basel : , : S. Karger, , 1989
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Neoadjuvant Chemotherapy : Current Applications in Clinical Practice / / edited by Oliver Bathe
Neoadjuvant Chemotherapy : Current Applications in Clinical Practice / / edited by Oliver Bathe
Pubbl/distr/stampa [Place of publication not identified] : , : InTech, , 2012
Descrizione fisica 1 online resource (270 pages)
Disciplina 615.58
Soggetto topico Chemotherapy
ISBN 953-51-6786-3
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Neoadjuvant chemotherapy
Record Nr. UNINA-9910137739903321
[Place of publication not identified] : , : InTech, , 2012
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Neue therapeutische Strategien in der hämatologischen Onkologie : : Symposium, Kiel, September 1988 / / editors, H. Löffler, W. Gassmann
Neue therapeutische Strategien in der hämatologischen Onkologie : : Symposium, Kiel, September 1988 / / editors, H. Löffler, W. Gassmann
Autore Löffler H
Pubbl/distr/stampa Basel : , : S. Karger, , 1989
Descrizione fisica 1 online resource (VI + 115 pages) : : 26 figures, 23 tables
Soggetto topico Oncology
Hematology
Chemotherapy
Immunology
Internal Medicine
ISBN 3-318-03419-3
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione ger
Record Nr. UNINA-9910156321503321
Löffler H  
Basel : , : S. Karger, , 1989
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
New Trends in Urinary Tract Infections : : The Single-Dose Therapy . International Symposium, Rome, January 1987 / / editors, H.C. Neu, J.D. Williams
New Trends in Urinary Tract Infections : : The Single-Dose Therapy . International Symposium, Rome, January 1987 / / editors, H.C. Neu, J.D. Williams
Autore Neu H.C
Pubbl/distr/stampa Basel : , : S. Karger, , 1988
Descrizione fisica 1 online resource (X + 358 pages) : : 57 figures, 121 tables
Disciplina 616.6/061
Altri autori (Persone) NeuHarold C. <1934->
WilliamsJ. D <1931 March-> (John David)
Soggetto topico Urology
Infectious Diseases
Chemotherapy
Microbiology
Pathology
Pharmacokinetics
Pharmacology
ISBN 3-318-04985-9
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910149650403321
Neu H.C  
Basel : , : S. Karger, , 1988
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Novel Approaches in Anticancer Drug Design : : Molecular Modelling - New Treatment Strategies.. International Symposium on Novel Approaches in Cacner Therapy, Heidelberg, December 1993 / / editors, W.J. Zeller, M. D'Incalci, D.R. Newell
Novel Approaches in Anticancer Drug Design : : Molecular Modelling - New Treatment Strategies.. International Symposium on Novel Approaches in Cacner Therapy, Heidelberg, December 1993 / / editors, W.J. Zeller, M. D'Incalci, D.R. Newell
Autore Zeller W.J
Pubbl/distr/stampa Basel : , : S. Karger, , 1995
Descrizione fisica 1 online resource (VIII + 196 pages) : : 84 figures, 8 in color, 28 tables
Soggetto topico Oncology
Pharmaceutics
Pharmacology
Chemotherapy
Toxicology
ISBN 3-318-03432-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910156288303321
Zeller W.J  
Basel : , : S. Karger, , 1995
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Nursing pharmacology made incredibly easy!
Nursing pharmacology made incredibly easy!
Edizione [Third edition.]
Pubbl/distr/stampa Philadelphia : , : Wolters Kluwer/Lippincott Williams & Wilkins Health, , [2013]
Descrizione fisica 1 online resource (736 pages) : illustrations (chiefly color)
Disciplina 615/.1
Collana Incredibly Easy! Series®
Soggetto topico Chemotherapy
Pharmacology
Nursing
Soggetto genere / forma Electronic books.
ISBN 1-4511-7901-4
1-4511-7920-0
1-4698-8054-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Fundamentals of nursing pharmacology -- Autonomic nervous system drugs -- Neurologic and neuromuscular drugs -- Pain medications -- Cardiovascular drugs -- Respiratory drugs -- Gastrointestinal drugs -- Genitourinary drugs -- Hematologic drugs -- Endocrine drugs -- Psychotropic drugs -- Anti-infective drugs -- Anti-inflammatory, antiallergy,and immunosuppressant drugs -- Antineoplastic drugs -- Drugs for fluid and electrolyte balance.
Record Nr. UNINA-9910463999503321
Philadelphia : , : Wolters Kluwer/Lippincott Williams & Wilkins Health, , [2013]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Oral Cephalosporins / / editor, R.C. Moellering Jr
Oral Cephalosporins / / editor, R.C. Moellering Jr
Autore Moellering Jr R.C
Pubbl/distr/stampa Basel : , : S. Karger, , 1995
Descrizione fisica 1 online resource (X + 190 pages) : : 13 figures, 44 tables
Disciplina 615.5/8 s
615/.32924
Altri autori (Persone) MoelleringRobert C
Collana Antibiotics and Chemotherapy
Soggetto topico Pharmacology
Infectious Diseases
Bacteriology
Chemotherapy
Pharmaceutics
Pharmacokinetics
ISBN 3-318-03222-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910156320503321
Moellering Jr R.C  
Basel : , : S. Karger, , 1995
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Organ Conservation in Curative Cancer Treatment : : Indications, Contraindications, Methods. 27th Annual San Fracisco Cancer Symposium, San Francisco, Calif., March 1992 / / editors, J.L. Meyer, J.M. Vaeth
Organ Conservation in Curative Cancer Treatment : : Indications, Contraindications, Methods. 27th Annual San Fracisco Cancer Symposium, San Francisco, Calif., March 1992 / / editors, J.L. Meyer, J.M. Vaeth
Autore Meyer J.L
Pubbl/distr/stampa Basel : , : S. Karger, , 1993
Descrizione fisica 1 online resource (XII + 256 pages) : : 36 figures, 89 tables
Disciplina 616.99/406
Altri autori (Persone) MeyerJohn <1949->
VaethJerome M. <1925->
Soggetto topico Radiology
Oncology
Chemotherapy
Gastroenterology
Gynecology
Otorhinolaryngology
Pathology
Surgery
Urology
ISBN 3-318-03717-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910157654203321
Meyer J.L  
Basel : , : S. Karger, , 1993
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Oxford handbook of practical drug therapy / / Duncan Richards [and three others]
Oxford handbook of practical drug therapy / / Duncan Richards [and three others]
Edizione [Second edition.]
Pubbl/distr/stampa New York, [New York] : , : Oxford University Press, , 2011
Descrizione fisica 1 online resource (818 p.)
Disciplina 615.1
Collana Oxford handbooks
Soggetto topico Drugs - Prescribing
Chemotherapy
Pharmacology
Soggetto genere / forma Electronic books.
ISBN 0-19-103388-X
0-19-172637-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Cover; Contents; Symbols and abbreviations; How to use this book; Introductory sections; Prescribing; The drug history; Writing a prescription; Generic drugs and biosimilars; Repeat prescriptions; 'Off-licence' drugs; Cautionary and advisory labels; Some basic concepts; The World Health Organization (WHO) essential medicines list; Compliance, adherence, and concordance; Guidelines; Dose-response curves (concentration-effect curves); Efficacy of drugs; Adverse drug reactions; Drug-drug interactions; Placebos; Changing the doses of drugs; Renal insufficiency; Hepatic insufficiency
An approach to rational prescribingPaediatric prescribing; Drugs and pregnancy; Drug therapy and breastfeeding; Drug development; 1 Gastrointestinal system; Gastric acid suppression; Histamine H[sub(2)] receptor antagonists: BNF 1.3.1; Proton pump inhibitors (PPIs): BNF 1.3.5; Misoprostol: BNF 1.3.4, 10.1.1; Drugs affecting gastrointestinal motility; Constipation: BNF 1.6; Co-phenotrope (Lomotil[sup(®)]): BNF 1.4.2; Loperamide (Imodium[sup(®)]): BNF 1.4.2; Inflammatory bowel disease; Mesalazine and related compounds (aminosalicylates): BNF 1.5; Sulfasalazine: BNF 1.5.1 and 10.1.3
Liver, biliary system, and lipidsCholic acids: BNF 1.9.1; HMG CoA reductase inhibitors ('statins'): BNF 2.12; Ezetimibe: BNF 2.12; Fibrates: BNF 2.12; Obesity; Orlistat: BNF 4.5.1; Antiemetics; Metoclopramide: BNF 4.6; Prochlorperazine (Stemetil[sup(®)]): BNF 4.6; Domperidone: BNF 4.6; Serotonin 5-HT[sub(3)] receptor antagonists: BNF 4.6; 2 Cardiovascular system; A pharmacological approach to the treatment of arrhythmias: BNF 2.3.1; Antiarrhythmic drugs; Adenosine: BNF 2.3.2; Flecainide BNF: 2.3.2; Cardiac glycosides (digitalis): BNF 2.1.1, 2.3.1, and 2.5.5; Disopyramide: BNF 2.3.2
Amiodarone: BNF 2.3.2 and 2.7.3Anticoagulants, antiplatelet drugs, and fibrinolytic drugs; Heparins (unfractionated and low molecular weight): BNF 2.8.1; Direct thrombin inhibitors: BNF 2.8.2; Fondaparinux sodium: BNF 2.8.1; Warfarin: BNF 2.8.2; Acetylsalicylic acid (aspirin): BNF 2.9 and 4.7.1; Clopidogrel: BNF 2.9; Dipyridamole: BNF 2.9; Glycoprotein IIb/IIIa antagonists: BNF 2.9; Fibrinolytic drugs: BNF 2.10.2 and 13.11.7; Ischaemic heart disease; Pharmacology of drugs used to treat acute coronary syndromes, including myocardial infarction: BNF 2.10
Pharmacology of drugs used to treat heart failureNitrate drugs: BNF 2.6.1; Nicorandil: BNF 2.6.3; Beta-adrenoceptor antagonists ('beta-blockers'): BNF 2.4, 2.5.5, 6.2.2, 4.7.4, 11.6; Angiotensin converting enzyme inhibitors (ACE inhibitors): BNF 2.5.5.1; Angiotensin receptor antagonists/blockers (ARBs): BNF 2.5.5.2; Hypertension; An approach to the treatment of hypertension: BNF 2.5; Methyldopa (alpha-methyldopa): BNF 2.5.2; Calcium channel blockers; Calcium channel blockers (see also individual sections): BNF 2.6.2; Dihydropyridines (nifedipine-like): BNF 2.6.2
Benzothiazepines (diltiazem): BNF 2.6.2 and 2.3.2
Record Nr. UNINA-9910464469103321
New York, [New York] : , : Oxford University Press, , 2011
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Oxford handbook of practical drug therapy / / Duncan Richards [and three others]
Oxford handbook of practical drug therapy / / Duncan Richards [and three others]
Edizione [Second edition.]
Pubbl/distr/stampa New York, [New York] : , : Oxford University Press, , 2011
Descrizione fisica 1 online resource (818 p.)
Disciplina 615.1
Collana Oxford handbooks
Soggetto topico Drugs - Prescribing
Chemotherapy
Pharmacology
Soggetto genere / forma Electronic books.
ISBN 0-19-104367-2
0-19-103388-X
0-19-172637-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Cover; Contents; Symbols and abbreviations; How to use this book; Introductory sections; Prescribing; The drug history; Writing a prescription; Generic drugs and biosimilars; Repeat prescriptions; 'Off-licence' drugs; Cautionary and advisory labels; Some basic concepts; The World Health Organization (WHO) essential medicines list; Compliance, adherence, and concordance; Guidelines; Dose-response curves (concentration-effect curves); Efficacy of drugs; Adverse drug reactions; Drug-drug interactions; Placebos; Changing the doses of drugs; Renal insufficiency; Hepatic insufficiency
An approach to rational prescribingPaediatric prescribing; Drugs and pregnancy; Drug therapy and breastfeeding; Drug development; 1 Gastrointestinal system; Gastric acid suppression; Histamine H[sub(2)] receptor antagonists: BNF 1.3.1; Proton pump inhibitors (PPIs): BNF 1.3.5; Misoprostol: BNF 1.3.4, 10.1.1; Drugs affecting gastrointestinal motility; Constipation: BNF 1.6; Co-phenotrope (Lomotil[sup(®)]): BNF 1.4.2; Loperamide (Imodium[sup(®)]): BNF 1.4.2; Inflammatory bowel disease; Mesalazine and related compounds (aminosalicylates): BNF 1.5; Sulfasalazine: BNF 1.5.1 and 10.1.3
Liver, biliary system, and lipidsCholic acids: BNF 1.9.1; HMG CoA reductase inhibitors ('statins'): BNF 2.12; Ezetimibe: BNF 2.12; Fibrates: BNF 2.12; Obesity; Orlistat: BNF 4.5.1; Antiemetics; Metoclopramide: BNF 4.6; Prochlorperazine (Stemetil[sup(®)]): BNF 4.6; Domperidone: BNF 4.6; Serotonin 5-HT[sub(3)] receptor antagonists: BNF 4.6; 2 Cardiovascular system; A pharmacological approach to the treatment of arrhythmias: BNF 2.3.1; Antiarrhythmic drugs; Adenosine: BNF 2.3.2; Flecainide BNF: 2.3.2; Cardiac glycosides (digitalis): BNF 2.1.1, 2.3.1, and 2.5.5; Disopyramide: BNF 2.3.2
Amiodarone: BNF 2.3.2 and 2.7.3Anticoagulants, antiplatelet drugs, and fibrinolytic drugs; Heparins (unfractionated and low molecular weight): BNF 2.8.1; Direct thrombin inhibitors: BNF 2.8.2; Fondaparinux sodium: BNF 2.8.1; Warfarin: BNF 2.8.2; Acetylsalicylic acid (aspirin): BNF 2.9 and 4.7.1; Clopidogrel: BNF 2.9; Dipyridamole: BNF 2.9; Glycoprotein IIb/IIIa antagonists: BNF 2.9; Fibrinolytic drugs: BNF 2.10.2 and 13.11.7; Ischaemic heart disease; Pharmacology of drugs used to treat acute coronary syndromes, including myocardial infarction: BNF 2.10
Pharmacology of drugs used to treat heart failureNitrate drugs: BNF 2.6.1; Nicorandil: BNF 2.6.3; Beta-adrenoceptor antagonists ('beta-blockers'): BNF 2.4, 2.5.5, 6.2.2, 4.7.4, 11.6; Angiotensin converting enzyme inhibitors (ACE inhibitors): BNF 2.5.5.1; Angiotensin receptor antagonists/blockers (ARBs): BNF 2.5.5.2; Hypertension; An approach to the treatment of hypertension: BNF 2.5; Methyldopa (alpha-methyldopa): BNF 2.5.2; Calcium channel blockers; Calcium channel blockers (see also individual sections): BNF 2.6.2; Dihydropyridines (nifedipine-like): BNF 2.6.2
Benzothiazepines (diltiazem): BNF 2.6.2 and 2.3.2
Record Nr. UNINA-9910664101203321
New York, [New York] : , : Oxford University Press, , 2011
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui